Physician profile
Christopher N Zingas
NPI 1215999339
$226,962.69
in general payments reported to CMS, 2019-2025
21 companies · $22K in 2025
The $22K reported for 2025 was more than what 85% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $38K · 2021: $53K · 2022: $56K · 2023: $30K · 2024: $3,952 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $39K · Consulting Fee: $12K · Travel and Lodging: $3,369 · Food and Beverage: $2,402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $39,014.39 |
| Consulting Fee | $11,625.00 |
| Travel and Lodging | $3,369.46 |
| Food and Beverage | $2,402.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $218,081.28 | 2019-2025 | Portfolio, Apex 3d, R3flex |
| Pinnacle, INC | $3,984.43 | 2019-2025 | |
| Stryker Corporation | $2,420.80 | 2019-2025 | Inbone, Gamma, Hoffmann |
| Arthrex, INC. | $1,129.90 | 2024-2025 | |
| Orthofix Medical, INC. | $176.27 | 2025 | Truelok |
| Kerecis Limited | $169.10 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Avanos Medical | $143.87 | 2025 | On-Q Pump and Accessories |
| Horizon Therapeutics Plc | $128.34 | 2019-2020 | |
| Treace Medical Concepts, INC. | $112.43 | 2024-2025 | |
| Depuy Synthes Sales INC. | $101.43 | 2024 | Na |
| Wright Medical Technology, INC. | $95.27 | 2019 | |
| Globus Medical, INC. | $76.09 | 2024 | Distal Femur Plate System |
| Medshape, INC. | $74.72 | 2025 | |
| Zimmer Biomet Holdings, INC. | $71.64 | 2023 | Trabecular Metal |
| Bioventus LLC | $71.22 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $32.83 | 2025 | Novosorb Btm |
| Convatec INC. | $32.10 | 2019-2020 | |
| Heron Therapeutics, INC. | $20.97 | 2024 | Zynrelef |
| Smith+Nephew, INC. | $17.54 | 2019 | |
| Acell, INC. | $11.61 | 2020 | |
| Kci USA, INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Zingas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.